This upcoming form of thin-film drug delivery is a more advanced alternative to the traditional forms of drug administration to the patients. The technique of thin-film drug delivery makes use of a thin film that dissolves quickly and easily, or an oral drug strip, which gets wet by the saliva in the mouth and swiftly hydrates and adheres to the site of application, a system that is in place to administer drugs via absorption directly in the mouth (buccally or sublingually) and/or through the small intestines (enterically).
A thin film is created using hydrophilic polymers, which rapidly dissolves on the tongue or in the buccal cavity, resulting in delivering the drug to the systemic circulation in the body via dissolution when contact is made with the liquid.
Referred to as oral thin films (OTFs), they have proven very effective for those patients who have trouble swallowing, because drugs can be delivered without the traditional techniques that require the patient to chew or swallow. Such patients include children, those experiencing nausea, and the growing geriatric community, which together make up about 37 percent of the total worldly population. This system of drug delivery is an attractive option for patients belonging to varied age demographics, because they don’t need to chew, swallow or drink water in order to ingest the drug.
The thin film covers a relatively large surface area, which allows for faster dissolution and disintegration. The thin strips can also be given a more likeable flavor and a more attractive color, for easy administration in the case of children. Because the films can be manipulated for precision dosing, this is useful for several cases, especially in the case of children who often need smaller doses, adults who need partial doses, and in the development of drugs where the production cannot make allowance for larger volume of doses.
In addition to the above mentioned advantages of this system, some others include, its cost effective nature, the efforts of scientists towards improving the therapeutic outputs of these drugs, the rapid advancements in related technology, funding from a variety of different organizations and governments, have all proven to act in favor of the thin film drugs market.
Thin Film Drugs Market Value Share Analysis, by Geography (2022)
The report titled “Thin Film Drugs Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global thin film drugs market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global thin film drugs market is segmented on the basis of Drug Type, Disease Indication, Distribution Channel, and geography. Based on Drug Type is segmented into Oral Thin Film Drugs, Transdermal Thin Film Drugs. Based on Disease Indication segmented into Schizophrenia, Migraine, Opioid Dependence, Others. Based on Distribution Channel is segmented into Hospital Pharmacy, Retail Pharmacy, Others. Based on geography is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on thin film drugs market. Further, market share of prominent companies in the global thin film drugs market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Thin Film Drugs companies. The global thin film drugs market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Thin Film Drugs business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global thin film drugs market.
The major players in the thin film drugs market include GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec, Tapemark, Prestige Bands, Sun Pharma, MonoSol, BioDelivery, Arx, ZIM, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx Corp, APR.
The Thin Film Drugs Market Is Segmented As Follows:
By Drug Type
By Disease Indication
By Distribution Channel
By Region
The rapid advancements in related technology, funding from a variety of different organizations and governments, have all proven to act in favor of the thin film drugs market.
The thin film drugs analysis market has been assessed for the years 2019 to 2032.
Based on Disease Indication, the thin film drugs market is segmented into Schizophrenia, Migraine, Opioid Dependence, Others.
Major players operating in the global thin film drugs market include GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec, Tapemark, Prestige Bands, Sun Pharma, MonoSol, BioDelivery, Arx, ZIM, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx Corp, APR and others.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved